Biden的行政当局从2027年开始,为医疗保险价格谈判挑选了15种药物,包括Ozempic。 Biden's administration picks 15 drugs, including Ozempic, for Medicare price negotiations starting in 2027.

拜登总统的政府挑选了15种新药物用于医疗药品价格谈判,包括治疗糖尿病和其他慢性病的Ozempic和Wegovy。 President Biden's administration has selected 15 new drugs for Medicare price negotiations, including Ozempic and Wegovy, which treat diabetes and other chronic conditions. 这些谈判定于2027年生效,目的是降低药品价格,在第一波省下医疗保险受益人约15亿美元。 These negotiations, set to take effect in 2027, aim to lower drug prices and save Medicare beneficiaries approximately $1.5 billion in the first wave. 制药业已经退缩,提出诉讼以阻止谈判。 The pharmaceutical industry has pushed back, filing lawsuits to halt the negotiations.